Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.

about

Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.

Item

http://www.wikidata.org/entity/Q47123520

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Short course hypofractionated ...... le institution phase II study.

@en

Short course hypofractionated ...... le institution phase II study.

@nl

type

Item

label

Short course hypofractionated ...... le institution phase II study.

@en

Short course hypofractionated ...... le institution phase II study.

@nl

prefLabel

Short course hypofractionated ...... le institution phase II study.

@en

Short course hypofractionated ...... le institution phase II study.

@nl

P1476

Short course hypofractionated ...... gle institution phase II study

@en

P2093

Adriana Faiella

http://www.w3.org/2001/XMLSchema#string

Alessia Farneti

http://www.w3.org/2001/XMLSchema#string

Carolina Giordano

http://www.w3.org/2001/XMLSchema#string

Giuseppe Iaccarino

http://www.w3.org/2001/XMLSchema#string

Giuseppe Sanguineti

http://www.w3.org/2001/XMLSchema#string

Lidia Strigari

http://www.w3.org/2001/XMLSchema#string

Valeria Landoni

http://www.w3.org/2001/XMLSchema#string

P2860

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials

Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.

Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.

The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies.

Impact of tumour bed boost integration on acute and late toxicity in patients with breast cancer: A systematic review.

Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

P2888

s13046-017-0640-z

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0640-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diana Giannarelli

Patrizia Vici

Paola Pinnarò

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100074575

http://www.w3.org/2001/XMLSchema#string

P698

29282078

http://www.w3.org/2001/XMLSchema#string

P932

5744389

http://www.w3.org/2001/XMLSchema#string